Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas

Cited by (144)

Items 101–144 of 144

1. Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma
   Xiunan Li, Jiayi Li, Leizuo Zhao, Zicheng Wang, Peizhi Zhang, Yingkun Xu, Guangzhen Wu · 2022 · Computational and Mathematical Methods in Medicine
2. Adrenocortical carcinoma: modern concepts of morphological diagnosis and classification
   Liliya S. Urusova, Irina S. Kletskaya, E. E. Porubayeva, D. G. Beltsevich · 2023 · Russian Journal of Archive of Pathology
3. Adrenocortical Growth and Cancer
   Lucile Lefèvre, Jerome Yves Bertherat, Bruno Ragazzon · 2015 · Comprehensive physiology
4. Adrenocortical Carcinoma
   Sara G Creemers, Leo J. Hofland, Richard Abraham Feelders · 2016 · Springer eBooks
5. The super-enhancer landscape reflects molecular subgroups of adrenocortical carcinoma
   Samuel Gunz, Gwenneg Kerdivel, Jonas Meirer, Igor Shapiro, Bruno Ragazzon, Floriane Amrouche, Marie-Ange Calméjane, Juliette Hamroune, Sandra Sigala, Alfredo Berruti et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
6. A new predictive factor VGF based on IHC experiments, gene pathways and molecular functional groups for tumor immune microenvironment and prognosis of adrenocortical carcinoma
   Junpeng Chi, Keyuan Lou, Jiankun Zhang, Jitao Wu, Yuanshan Cui · 2025 · Frontiers in Immunology
7. Adrenocortical carcinoma: From genomics to patients
   Victor Gravrand, Anne Jouinot, Guillaume Assié · 2026 · Annales d Endocrinologie
8. Novel Insights into G0S2 as a Central Regulator of Lipid Metabolism and Its Implications for Meat Quality
   Li Han, Hongkun Li, Jiajie Ouyang, Chunru Lu, Tao Jing, Hexia Gan, Jie Yin, Qiyu Tian, Xingguo Huang · 2026 · Animals
9. CpG Island Methylator Phenotype in Adrenocortical Carcinoma: Fact or Fiction?
   Yi Liu‐Chittenden, Electron Kebebew · 2013 · The Journal of Clinical Endocrinology & Metabolism
10. Application of molecular pathology in endocrine pathology
    Ebru Serinsöz, Gaye Güler Tezel · 2015 · Turkish Journal of Pathology
11. Genetics of Adrenocortical Cancers
    Guillaume Assié, Jerome Yves Bertherat · 2016 · Springer eBooks
12. Adrenocortical Carcinoma
    Bruno Allolio, Martin Faßnacht · 2015 · Elsevier eBooks
13. Proteína Esterol O-acilcoenzima A: colesterol aciltransferase 1 (SOAT1): um novo marcador preditivo de agressividade dos carcinomas do córtex suprarrenal
    Amanda Meneses Ferreira Lacombe · 2020
14. Biomarkers in Endocrine Organ Carcinomas
    Yasemin Sahin, Merih Güray Durak, Özgür Mete · 2022 · Springer eBooks
15. Adrenal Neoplasms
    Ashley A. Stewart, Ellen Shannon Story · 2017 · Wiley eBooks
16. Adrenocortical Carcinoma: Genetics and Molecular Markers
    Anne Jouinot, Guillaume Assié · 2018 · Elsevier eBooks
17. Adrenal Cortex
    Hironobu Sasano, Yuto Yamazaki · 2017 · AJSP Review and Reports
18. Análise da regulação do fator de transcrição TCF21 e seu papel na migração e invasão celular em tumores.
    Jean Lucas Kremer · 2020
19. Hereditary Endocrine Tumor Registries
    Edwina C. Moore, Liane Ioannou, Rasa Ruseckaite, Jonathan W. Serpell, Susannah Ahern · 2022 · Journal of the Endocrine Society
20. Genetics of adrenal tumors
    Antônio Marcondes Lerário, Dipika R. Mohan, Thomas J. Giordano, Gary Douglas Hammer · 2023 · Elsevier eBooks
21. Additional file 9 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
22. Additional file 5 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
23. Additional file 13 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
24. Additional file 12 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
25. Additional file 4 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
26. Additional file 2 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
27. Additional file 10 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
28. Additional file 3 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
29. Additional file 7 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
30. Additional file 6 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
31. Additional file 8 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
32. Additional file 11 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
33. Additional file 1 of DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
    Gwenneg Kerdivel, Floriane Amrouche, Marie-Ange Calméjane, Floriane Carallis, Juliette Hamroune, Constanze Hantel, Jerome Yves Bertherat, Guillaume Assié, Valentina Boeva · 2023 · Figshare
34. Additional file 1 of Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
    Tito Fojo, Lyn Mickley Huff, Litman, Thomas, Im, Kate, Maureen Edgerly, del Rivero, Jaydira, Stefania Pittaluga, Merino, Maria, Susan Elaine Bates, Michael C. Dean · 2020 · Figshare
35. Adrenocortical carcinoma: Genetics and molecular markers
    Antoan Stefan Šojat, Anne Jouinot, Guillaume Assié · 2026 · Elsevier eBooks
36. Construction of a Prognostic Risk Model for Helicobacter pylori Infection in Gastric Cancer Patients and Immunological Analysis
    Zhiying Tian, Miao Su, Bin Yang, Zhaoyun Zhang, Li Zhang · 2026 · Cancer Reports
37. Progression tumorale dans un modèle murin de carcinogénèse surrénalienne ciblée induite par antigène T de SV 40 : Recherche de cibles thérapeutiques pour le corticosurrénalome.
    Marie Batisse‐Lignier · 2016 · theses.fr (ABES)
38. Génomique intégrée des tumeurs bénignes corticosurrénaliennes
    Simon Faillot · 2017 · theses.fr (ABES)
39. Marqueurs moléculaires ciblés pour le pronostic et le traitement des corticosurrénalomes : de la génomique à la médecine personnalisée
    Anne Jouinot · 2020
40. Hétérogénéité moléculaire de l'hyperplasie macronodulaire des surrénales
    Anna Vaczlavik · 2021
41. PCDHGC3 promoter methylation identifies malignancy and poor prognosis in adrenocortical tumors
    Tamara Cubiella, Jaime Costas, Álvaro Suárez‐Priede, Jaime San‐Juan‐Guardado, Raúl Rodríguez‐Aguilar, Y Rey Fanjul, Francisco Domínguez, Nerea Gomez-Suarez, Ivan Fernández‐Vega, Felicia Alexandra Hanzu et al. · 2026 · Research Square
42. Systemic management of adrenal malignancies: adrenocortical carcinoma and pheochromocytoma/paraganglioma
    Jorge Humberto Hernández-Félix, Marta Lagana, Deborah Cosentini, Maria Chiara Tacchetti, Alfredo Berruti, Jaydira Del Rivero · 2026 · Endocrine Connections
43. Single-cell resolution in adrenocortical carcinoma: from pathogenesis to treatment
    Dipika R. Mohan, Gary Douglas Hammer, Antônio Marcondes Lerário · 2026 · Current Opinion in Endocrinology Diabetes and Obesity
44. A proteome-based classification of paediatric adrenocortical tumours links functional tumour states to clinical outcome and therapeutic vulnerabilities
    Rainer Claus, Andreas Metousis, Victoria E. Fincke, Marina Kunstreich, Stefan Alexander Wudy, Eva Jüttner, Jörn Pons‐Kühnemann, Christian Vokuhl, MC Frühwald, Christoph Röcken et al. · 2026 · EBioMedicine